Gln-Arg192 polymorphism of paraoxonase and coronary heart disease in type 2 diabetes

This publication has 21 references indexed in Scilit:

• Plasma Oxidizability in Subjects With Normal Glucose Tolerance, Impaired Glucose Tolerance, and NIDDM
  Diabetes Care, 1995
• A Polymorphism of the Paraoxonase Gene Associated With Variation in Plasma Lipoproteins in a Genetic Isolate
  Arteriosclerosis, Thrombosis, and Vascular Biology, 1995
• Blood pressure, coronary artery disease, and glycaemic control in type 2 diabetes mellitus: relation to apolipoprotein-CIII gene polymorphism
  The Lancet, 1994
• Protection of low-density lipoprotein against oxidative modification by high-density lipoprotein associated paraoxonase
  Atherosclerosis, 1993
• Identification of a distinct human high‐density lipoprotein subspecies defined by a lipoprotein‐associated protein, K‐45
  European Journal of Biochemistry, 1993
• Oxidized Low Density Lipoproteins: a Role in the Pathogenesis of Atherosclerosis in Diabetes?
  Diabetic Medicine, 1991
• High-density lipoprotein inhibits the oxidative modification of low-density lipoprotein
  Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1990
• The Prospective Cardiovascular Münster (PROCAM) study: Prevalence of hyperlipidemia in persons with hypertension and/or diabetes mellitus and the relationship to coronary heart disease
  American Heart Journal, 1988
• Lipid peroxide levels of serum lipoprotein fractions of diabetic patients
  Biochemical Medicine, 1981
• Calculation of Attributable Risks from Epidemiological Data
  International Journal of Epidemiology, 1978